NIMHANS signs MoU to establish a research centre
The five-year partnership is aimed at bridging traditional Indian healing systems with modern medical science, focusing on evidence-based research in yoga, naturopathy, and their integration into mainstream healthcare. The Memorandum of Understanding (MoU) was signed by CCRYN director Raghavendra Rao and NIMHANS director Pratima Murthy.
According to a press release from NIMHANS, Hemant Bhargav, Associate Professor of Integrative Medicine at NIMHANS, will serve as the Principal Investigator for the collaborative centre. The research team will comprise doctors - Kishore Kumar R., Nishitha Jasti, Bharath Holla, and Shivakumar from NIMHANS, and Vadiraja and Inbaraj from CCRYN, bringing together expertise from both institutions in this collaborative effort to advance the science of mind-body medicine, the release said.
Under this collaboration, the institutions will jointly conduct research projects examining the efficacy of mind-body interventions for conditions including mental health disorders, metabolic disorders and neurological conditions. The initiative will also focus on training healthcare professionals and developing standardised protocols for integrative treatment approaches, the release added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
She moved to the US at 11. India-origin CEO in Fortune's list with Ambani and Adani. Check education and career of Reshma Kewalramani
Who is Reshma Kewalramani? Reshma Kewalramani's education background and career Fortune 100 Most Powerful People in Business From Bombay to the boardrooms of one of the world's leading biotech firms, Reshma Kewalramani 's journey is nothing short of extraordinary. The Indian-origin CEO, who moved to the US at the age of 11, now leads Vertex Pharmaceuticals—one of the world's top Fortune 500 companies. With a Harvard education, she's not only one of the most powerful women in global business but also among the wealthiest of Indian Kewalramani, MD, FASN, is the Chief Executive Officer and President of Vertex Pharmaceuticals , a global biotech powerhouse known for developing life-changing medicines. She joined the company in 2017 and quickly rose through the ranks, serving as Chief Medical Officer and EVP of Global Medicines Development before being appointed CEO in 2020. Under her leadership, Vertex has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis (CF), transforming the lives of thousands of journey began in medicine. Kewalramani earned her medical degree with honours from the seven-year program at Boston University Chobanian & Avedisian School of Medicine. She completed her internship and residency in internal medicine at Massachusetts General Hospital, followed by a fellowship in nephrology at the joint program between Mass General and Brigham and Women's Hospital. Later, she expanded her expertise into leadership, completing the General Management Program at Harvard Business School.A Fellow of the American Society of Nephrology, Kewalramani has been widely recognised for her impact in healthcare and leadership. She has been named to both the TIME 100 Most Influential People in the World and TIME 100 Health lists, cementing her reputation as a visionary in the biotech industry Nvidia CEO and cofounder Jensen Huang has landed the No. 1 spot on Fortune's 2025 list of the world's 100 most powerful businesspeople. The other tech heavyweights in the top 10—Microsoft's Satya Nadella, Meta's Mark Zuckerberg, Alphabet's Sundar Pichai, and Huawei's Ren Zhengfei—are all chasing after more of Huang's in-demand chips. But even at the top, there's no time to relax. With powerful rivals closing in, Huang knows the pressure is always on.
Economic Times
34 minutes ago
- Economic Times
Superfood is the biggest health scam? 5 expert-backed truths to save your health and wallet
You've heard it all before: 'Add quinoa to your meals, it's a superfood!', 'Chia seeds can save your heart!', 'Goji berries fight ageing!' But before you empty your wallet for another imported pouch of seeds, here's a reality check: superfoods don't actually exist. Not in the way we've been made to marketing, a 'superfood' is anything packed with nutrients, berries, seeds, grains, that's promoted as a miracle cure for your body. But ask any scientist, and they'll tell you: there's no official or scientific definition for the word. According to Harvard experts, the term superfood has 'no scientifically based or regulated definition.' The European Union has even banned using it on labels, unless there's strong scientific proof to back the UK's NHS also warns that the word is often overstated and misleading. British dietitian Catherine Collins says such labels make people wrongly believe that ordinary foods are somehow lacking. And that's simply not short: superfoods are a myth, just clever marketing wrapped in healthy-sounding buzz. Health experts around the world agree on one thing: no single food can fix World Health Organization (WHO) advises eating a varied, plant-based diet with plenty of fruits, vegetables, legumes and whole grains. Their guidelines suggest at least 400 grams of fruits and vegetables a day, not just blueberries and chia seeds, but whatever's fresh and India, the 2024 Dietary Guidelines by the ICMR and NIN echo the same: no single food provides all nutrients. A healthy diet should include a mix of cereals, pulses, greens, fruits, nuts and dairy. They even warn against relying on trendy protein powders, saying most people get enough protein from natural The Guardian said back in 2016: 'If you eat a balanced diet with plenty of fruit and vegetables and do regular exercise, nothing is a superfood.'India's growing health-conscious middle class has been swept up in the superfood hype. Supermarkets now stack quinoa, chia seeds, goji berries, kale, and 'super juices' flown in from while these foreign foods sound glamorous, they're often expensive, imported, and unnecessary. Worse, they're replacing our own traditional ingredients, which are just as nutritious, if not example: Quinoa is praised for being protein-rich. But ragi (finger millet), a native Indian grain, has more calcium and is far seeds are loaded with omega-3, but so are flax seeds and sabja (basil seeds)—both berries hype antioxidants, but amla (Indian gooseberry) has more Vitamin C and costs eat avocados for good fats, yet India's own coconut and ghee offer rich gym-goers chase protein powders, traditional foods like daal-roti or sattu give protein, iron and fibre, without traditional foods are our real superfoods. And guess what? The government knows it too. Campaigns now promote millets, moringa, and pulses as sustainable, nutrient-rich crops we've always had but break down the problems with this superfood obsession: 1. They're Expensive Harvard's nutrition research points out that many 'superfoods' are costly and unnecessary. Instead of buying imported berries or powders, you could get better nutrition from a basket of local veggies. 2. They Create Unbalanced Diets Eating the same 'super' item every day isn't healthy. As the NHS warns, no single food can prevent disease or boost immunity alone. A smoothie bowl can't cancel out a junk meal. 3. They Harm the Environment Shipping kale or quinoa across continents adds to carbon emissions. Meanwhile, local crops like millets grow naturally in Indian soil, need less water, and support Indian farmers. 4. They Spread Misinformation Marketing makes big promises, 'detox,' 'anti-ageing,' 'miracle cure.' But many of these claims are not backed by science. Even Europe's top food safety agency has rejected health claims for several so-called superfoods. The good news? You don't need to hunt for food from the Amazon rainforest or the Peruvian Andes. Everything your body needs is already in your Ragi instead of quinoa Amla instead of goji berries Sabja or flax seeds instead of chia Moringa (drumstick leaves) instead of kale Turmeric instead of spirulina Pulses and sattu instead of protein powder These local options are nutrient-rich, budget-friendly, eco-friendly, and delicious. So the next time you see a fancy pack claiming to be a "superfood", remember this: there's no scientific stamp behind it. Your grandmother's recipes, local markets and seasonal produce offer more power than any trendy tradition. Trust science. Trust your own the real superfood? It's probably already on your plate.
Economic Times
an hour ago
- Economic Times
She moved to the US at 11. India-origin CEO in Fortune's list with Ambani and Adani. Check education and career of Reshma Kewalramani
Synopsis Reshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals, a Fortune 500 biotech firm, after moving to the US at 11. A Harvard graduate, she rose through the ranks to CEO in 2020, securing approval for five breakthrough cystic fibrosis drugs. Recognized by TIME, Kewalramani exemplifies science, leadership, and perseverance in modern medicine. Reshma Kewalramani is the CEO and President at Vertex Pharmaceuticals. (LinkedIn) From Bombay to the boardrooms of one of the world's leading biotech firms, Reshma Kewalramani's journey is nothing short of extraordinary. The Indian-origin CEO, who moved to the US at the age of 11, now leads Vertex Pharmaceuticals—one of the world's top Fortune 500 companies. With a Harvard education, she's not only one of the most powerful women in global business but also among the wealthiest of Indian Kewalramani, MD, FASN, is the Chief Executive Officer and President of Vertex Pharmaceuticals, a global biotech powerhouse known for developing life-changing medicines. She joined the company in 2017 and quickly rose through the ranks, serving as Chief Medical Officer and EVP of Global Medicines Development before being appointed CEO in 2020. Under her leadership, Vertex has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis (CF), transforming the lives of thousands of patients. Her journey began in medicine. Kewalramani earned her medical degree with honours from the seven-year program at Boston University Chobanian & Avedisian School of Medicine. She completed her internship and residency in internal medicine at Massachusetts General Hospital, followed by a fellowship in nephrology at the joint program between Mass General and Brigham and Women's Hospital. Later, she expanded her expertise into leadership, completing the General Management Program at Harvard Business School. A Fellow of the American Society of Nephrology, Kewalramani has been widely recognised for her impact in healthcare and leadership. She has been named to both the TIME 100 Most Influential People in the World and TIME 100 Health lists, cementing her reputation as a visionary in the biotech industry. Nvidia CEO and cofounder Jensen Huang has landed the No. 1 spot on Fortune's 2025 list of the world's 100 most powerful businesspeople. The other tech heavyweights in the top 10—Microsoft's Satya Nadella, Meta's Mark Zuckerberg, Alphabet's Sundar Pichai, and Huawei's Ren Zhengfei—are all chasing after more of Huang's in-demand chips. But even at the top, there's no time to relax. With powerful rivals closing in, Huang knows the pressure is always on.
